Overview

Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study

Status:
Completed
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if nicotine treatment is beneficial for the treatment of sarcoidosis. Sarcoidosis is a disease of unknown cause that leads to inflammation. This disease affects your body's organs.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ohio State University
Collaborator:
The Cleveland Clinic
Treatments:
Nicotine